Gilead HIV Cure Mentored Scientist Awards

Note: The Gilead HIV Cure Mentored Scientist award is currently being offered during the Fall 2023 RAP Cycle, deadline October 2, 2023.  

The purpose of the Gilead HIV Cure Mentored Scientist Award at the amfAR Institute for HIV Cure Research is to mentor and train early stage investigators participating in HIV cure research. The award is open to investigators at a senior stage of clinical or postdoctoral training, and to new faculty at UCSF and affiliated partner institutes. Cure research projects can be in behavioral, clinical or basic laboratory science. Applications including research participants from underserved populations or from investigators underrepresented in HIV cure science are particularly encouraged. Applicants for this award must indicate a faculty research mentor(s) who will commit to guiding the applicant throughout the duration of the proposed project. Funded through the ARI, the application is processed through the UCSF Resource Allocation Program (RAP).

The award amount for this program is $45,000 in direct costs for one year.

For more information, please see the RAP portal.

Spring 2023 Awardee

Francisco José Zapatero Belinchón, PhD

Development and delivery of next-generation epigenome editors for long-term HIV silencing

Spring 2022 Awardee

Ashley George, PhD

Deep phenotyping of NK cells from HIV+ individuals undergoing antiretroviral treatment interruption 

Spring 2020 Awardee

Koh Fujinaga, PhD

Improving efficacies of latency reversing agents by increasing CycT1 proteins in latently infected cells

Fall 2019 Awardees

Amelia Deitchman, PharmD, PhD

Defining sirolimus dosing targets for HIV cure

Zain Dossani, PhD

Deciphering the regulation of CD8+ T cell hyporesponsiveness in HIV infection by interrogating chromatin accessibility at the single-cell level

Spring 2019 Awardee

Michael Peluso, MD

A comprehensive immunologic analysis of HIV ‘extraordinary’ controllers as a model for durable HIV suppression

Spring 2018 Awardees

Rachel Rutishauser, MD, PhD

Exploring the role of TCF-7 in the regulation of HIV-specific CD8+ T Cell

Daniela Boehm, PhD

Targeting SMYD5 Mediated Tat Methylation to Silence Latent HIV-1

Spring 2017 Awardees

Leonard Chavez, PhD

Replenishment of the HIV reservoir following reactivation of latent HIV

Andrea Gramatica, PhD

Identifying potent, non-toxic latency reversing agents that function through the mTOR pathway